213 related articles for article (PubMed ID: 15017664)
1. Studying pruritus in the 21st century.
Bergasa NV
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):249-51. PubMed ID: 15017664
[No Abstract] [Full Text] [Related]
2. Natural history of pruritus in primary biliary cirrhosis.
Talwalkar JA; Souto E; Jorgensen RA; Lindor KD
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):297-302. PubMed ID: 15017671
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
4. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
Corpechot C; Abenavoli L; Rabahi N; Chrétien Y; Andréani T; Johanet C; Chazouillères O; Poupon R
Hepatology; 2008 Sep; 48(3):871-7. PubMed ID: 18752324
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis].
Avezov SA; Mansurov FKh
Klin Med (Mosk); 2004; 82(3):55-8. PubMed ID: 15114777
[TBL] [Abstract][Full Text] [Related]
6. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study.
Nakai S; Masaki T; Kurokohchi K; Deguchi A; Nishioka M
Am J Gastroenterol; 2000 Jan; 95(1):326-7. PubMed ID: 10638623
[No Abstract] [Full Text] [Related]
8. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.
Angulo P; Dickson ER; Therneau TM; Jorgensen RA; Smith C; DeSotel CK; Lange SM; Anderson ML; Mahoney DW; Lindor KD
J Hepatol; 1999 May; 30(5):830-5. PubMed ID: 10365809
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of primary biliary cirrhosis].
Szalay F
Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
[No Abstract] [Full Text] [Related]
10. [The treatment of primary biliary liver cirrhosis with rifampicin].
Loginov AS; Reshetniak VI; Petrakov AV
Ter Arkh; 1993; 65(8):57-62. PubMed ID: 8211805
[TBL] [Abstract][Full Text] [Related]
11. [Cholestatic liver diseases--diagnosis and therapy. 3: Therapy of primary biliary cirrhosis].
Leuschner U
Fortschr Med; 1998 Jan; 116(1-2):37-9. PubMed ID: 9522537
[No Abstract] [Full Text] [Related]
12. Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary cirrhosis: a 2-year follow-up study.
Zhu J; Shi Y; Zhou X; Li Z; Huang X; Han Z; Wang J; Wang R; Ding J; Wu K; Han Y; Fan D
Front Med; 2013 Jun; 7(2):255-63. PubMed ID: 23179137
[TBL] [Abstract][Full Text] [Related]
13. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of primary biliary cirrhosis. The effect of ursodeoxycholic acid is questioned now].
Broomé U
Lakartidningen; 2000 May; 97(21):2585-7. PubMed ID: 10881517
[No Abstract] [Full Text] [Related]
16. Colestimide: the efficacy of a novel anion-exchange resin in cholestatic disorders.
Matsuzaki Y
J Gastroenterol Hepatol; 2002 Nov; 17(11):1133-5. PubMed ID: 12453270
[No Abstract] [Full Text] [Related]
17. Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis.
Roda E; Azzaroli F; Nigro G; Piazza F; Jaboli F; Ferrara F; Liva S; Giovanelli S; Miracolo A; Colecchia A; Festi D; Mazzeo C; Bacchi L; Roda A; Mazzella G
Dig Liver Dis; 2002 Jul; 34(7):523-7. PubMed ID: 12236487
[TBL] [Abstract][Full Text] [Related]
18. Are therapeutic doses of ursodeoxycholic acid in the cure of primary biliary cirrhosis inadequate? Some clinical considerations.
Caponi A; Lisotti A; Grenci C; Roda E
Minerva Gastroenterol Dietol; 2008 Dec; 54(4):331-4. PubMed ID: 19047973
[No Abstract] [Full Text] [Related]
19. THE LONG TERM USE OF CHOLESTYRAMINE IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS.
SCHAFFNER F; KLION FM; LATUFF AJ
Gastroenterology; 1965 Mar; 48():293-8. PubMed ID: 14292140
[No Abstract] [Full Text] [Related]
20. A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
Hirschfield GM; Bowlus CL; Mayo MJ; Kremer AE; Vierling JM; Kowdley KV; Levy C; Villamil A; Ladrón de Guevara Cetina AL; Janczewska E; Zigmond E; Jeong SH; Yilmaz Y; Kallis Y; Corpechot C; Buggisch P; Invernizzi P; Londoño Hurtado MC; Bergheanu S; Yang K; Choi YJ; Crittenden DB; McWherter CA;
N Engl J Med; 2024 Feb; 390(9):783-794. PubMed ID: 38381664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
